Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 14 de jun. de 2021 · This guideline provides recommendations on the use of fidaxomicin and bezlotoxumab for the treatment of Clostridioides difficile infection (CDI) in adults. It is intended for healthcare professionals who care for adults with CDI and is based on the latest evidence and expert consensus.

  2. 15 de feb. de 2018 · Summarized below are recommendations intended to improve the diagnosis and management of Clostridium difficile infection (CDI) in adults and children. CDI is defined by the presence of symptoms (usually diarrhea) and either a stool test positive for C. difficile toxins or detection of toxigenic C. difficile , or colonoscopic or ...

  3. 19 de oct. de 2021 · European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults - Clinical Microbiology and Infection. Guidelines | Volume 27, SUPPLEMENT 2, S1-S21, December 2021. Download Full Issue.

  4. 1 de jun. de 2021 · Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent the official practice recommendations of the American ….

  5. 7 de sept. de 2021 · This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.

  6. 28 de nov. de 2022 · Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults.

  7. 16 de abr. de 2020 · In addition, two guidelines for C. difficile have been proposed, but few data are available on their efficacy and safety in paediatric age groups. The aim of this article is to review diagnostic laboratory methods that are now available to detect C. difficile and to discuss the most recent recommendations on CDI therapy in children.